IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $158,000 | -79.1% | 10,000 | -75.0% | 0.03% | -79.7% |
| Q2 2017 | $755,000 | +10.7% | 40,000 | 0.0% | 0.14% | +10.0% |
| Q1 2017 | $682,000 | +11.4% | 40,000 | 0.0% | 0.13% | +6.6% |
| Q4 2016 | $612,000 | -3.6% | 40,000 | 0.0% | 0.12% | -6.9% |
| Q3 2016 | $635,000 | +21.4% | 40,000 | 0.0% | 0.13% | +18.0% |
| Q2 2016 | $523,000 | +11.3% | 40,000 | 0.0% | 0.11% | +11.0% |
| Q1 2016 | $470,000 | +1.3% | 40,000 | 0.0% | 0.10% | +5.3% |
| Q4 2015 | $464,000 | +11.3% | 40,000 | 0.0% | 0.10% | +5.6% |
| Q3 2015 | $417,000 | -13.5% | 40,000 | 0.0% | 0.09% | -4.3% |
| Q2 2015 | $482,000 | -24.7% | 40,000 | 0.0% | 0.09% | -24.2% |
| Q1 2015 | $640,000 | +4.4% | 40,000 | 0.0% | 0.12% | +3.3% |
| Q4 2014 | $613,000 | +18.3% | 40,000 | 0.0% | 0.12% | +14.3% |
| Q3 2014 | $518,000 | -15.5% | 40,000 | 0.0% | 0.10% | -13.2% |
| Q2 2014 | $613,000 | +24.3% | 40,000 | 0.0% | 0.12% | +19.8% |
| Q1 2014 | $493,000 | – | 40,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |